Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
https://www.zenithepigenetics.com/upload/media_element/129/01/zenith-sabcs-2020-poster-dec.-9-2020.pdf